NEK2 is documented to be overexpressed in breast-cancer tissue relative to normal tissue (Hayward et al., 2004; Cappello et al., 2014), and is required for the growth, maintenance and survival of the transformed cell (Lee and Gollahon, 2013). Here, NEK2 is linked to breast carcinoma.